Moran Wealth Management, LLC Argenx Se Transaction History

Moran Wealth Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$369.35 - $548.43 $46,538 - $69,102	-126 Reduced 1.96%	6,312 $3.1 Million
Q2 2023 Aug 10, 2023	SELL	$360.14 - $422.58 $43,576 - $51,132	-121 Reduced 1.84%	6,438 $2.51 Million
Q1 2023 May 10, 2023	SELL	$334.23 - $403.65 $70,522 - $85,170	-211 Reduced 3.12%	6,559 $2.44 Million
Q4 2022 Feb 13, 2023	BUY	$342.17 - $402.31 $2.32 Million - $2.72 Million	6,770 New	6,770 $0

400

30.9M

376K

489K

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $34.8B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

Get notified when there are updates to the investment portfolio of Moran Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Moran Wealth Management, LLC with notifications on news.